IceCure Medical (ICCM) Cash from Operations (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Cash from Operations data on file, last reported at 4271000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 5.77% year-over-year to 4271000.0 in Q1 2026; TTM through Mar 2026 was 14807000.0, a 7.7% decrease from a year earlier, with the FY2025 full-year figure at 14574000.0, down 16.01% from the prior year.
• Cash from Operations for Q1 2026 stood at 4271000.0, up from 5019000.0 in the prior quarter.
• Over the last five years, Cash from Operations for ICCM reached as high as 2304000.0 in Q4 2023 and fell as low as 5019000.0 in Q4 2025.
• Historically, Cash from Operations has averaged 3426470.59 across 5 years, with a median of 3319000.0 in 2022.
• Across the five-year window, Cash from Operations sank 120.31% in 2022 and soared 44.19% in 2023, its largest moves.
• Year by year, Cash from Operations stood at 4128000.0 in 2022, then surged by 44.19% to 2304000.0 in 2023, then plunged by 82.07% to 4195000.0 in 2024, then slipped by 19.64% to 5019000.0 in 2025, then advanced by 14.9% to 4271000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 4271000.0 in Q1 2026, 5019000.0 in Q4 2025, and 2705000.0 in Q3 2025.